- Home
- AIRI vs OSRH Comparison
AIRI vs OSRH Comparison
Compare AIRI & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AIRI | OSRH |
|---|---|---|
| Founded | 1979 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9M | 18.4M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | AIRI | OSRH |
|---|---|---|
| Price | $3.31 | $0.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 154.2K | ★ 391.1K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $55,108,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.53 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.97 | N/A |
| 52 Week Low | $2.55 | $0.38 |
| 52 Week High | $4.17 | $4.33 |
Technical Indicators
Market Signals| Indicator | AIRI | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 51.06 | 51.70 |
| Support Level | $3.18 | $0.45 |
| Resistance Level | $3.34 | $0.76 |
| Average True Range (ATR) | 0.17 | 0.05 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 60.92 | 59.82 |
Price Performance
Historical ComparisonAbout AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.